What Happens When You Stop Taking NMN, and Why People Stop
Nothing harmful happens when you stop taking NMN. There is no withdrawal and no rebound, because NMN is a step on the vitamin B3 pathway your body runs anyway, and the extra NAD it put into your blood drifts back to your own baseline over the weeks that follow. No trial has measured people after they stopped, so every day-by-day timeline online is extrapolation. What the trials do show is that NMN's breakdown products clear from the blood within hours of a dose,1 that blood NAD took weeks of daily dosing to rise,2, 3 and that the one functional finding, a longer six-minute walk in 80 adults at 300 to 900 mg a day over 60 days, was measured while people were still taking it.4 NMN builds nothing structural, so there is nothing to lose; what you keep is whatever walking, sleeping or training you did in the meantime.
- Harm from stopping: none; no dependence, no taper
- What fades: the rise in blood NAD, over weeks rather than days, at an unmeasured rate
- What you keep: everything that was yours anyway; NMN does not build tissue
- Restarting: the same dose, with food; no loading
What happens to your NAD when you stop?
It goes back to where it was. In the first human safety study, a single dose of 100 to 500 mg raised nicotinamide breakdown products in the blood and they were falling again within the five-hour window.1 In the 12-week Japanese studies, blood NAD rose on 250 mg a day and the rise was still there at the end, which tells you the pool is maintained by daily intake rather than filled once.2, 3 Nobody has drawn blood a month after stopping, but the mechanism is not mysterious: your cells make NMN from the nicotinamide in food every day, and when the capsule stops, that is the supply you are back to. A vitamin pathway does not register the difference as withdrawal. It registers nothing at all.
How long does NMN take to start working, and how can you tell?
Blood NAD rises within days and levels off within weeks.2, 3 Anything you might notice takes longer and is smaller. In the 60-day trial, the six-minute walk was already longer than placebo at day 30 and more so at day 60, at every dose from 300 to 900 mg and most at 600 mg;4 in the 12-week trial of 108 older adults, afternoon drowsiness fell in those taking NMN in the afternoon, while sleep quality overall did not change.5 So the fair window is 60 to 90 days. How to tell: pick one thing you can score before you start, because "I think I feel a bit better" is the least reliable instrument you own. A timed walk round the block, the stairs at work, how many afternoons a week you nap, how long your usual run takes. Score it in week one and week nine, and change nothing else in between, because a new pair of trainers or lighter evenings will move the number faster than any capsule. If it hasn't moved, you have your answer, and nothing in the trials says it needs longer. Commercial NAD blood tests exist; they confirm what every trial already shows, that the number goes up, and say nothing about whether you'll notice it.
Why can you only take NMN for 12 weeks?
You can take it for longer; 12 weeks is how long trials tend to run, not a safety limit. The human studies lasted from two weeks to 24 weeks: 28 days in the high-dose American study, 60 days in the 80-person trial, ten weeks in the prediabetes trial, six or twelve weeks in the Japanese studies, 24 weeks at the longest, with 12 the commonest because it is long enough to see a blood change and short enough to fund.6 The "12 weeks" rule circulating online was lifted from those durations and from packs that suggest a 12-week course, and then hardened into a warning. The European Food Safety Authority's 2026 assessment considered 300 mg a day for adults as continuous daily use with no stopping instruction, and excluded only pregnant and breastfeeding women.7 What is true is that nobody has studied NMN beyond 24 weeks, so nothing is known about years of use either way.6
How long should you stay on NMN?
As long as it is doing something you can measure, within the limits of a trial record that stops at 24 weeks. The 60-day trial-sized test above is the first stage. If something moved, the question becomes whether it holds, and the trials suggest the effects track intake: stop, and the blood NAD goes back, and anything that depended on it presumably goes with it. If nothing moved, there is no evidence that month six will differ from month two. Cycling, taking breaks on a schedule, has no trial behind it in either direction; the studies dosed every day without breaks. Across 15 trials at 250 to 2,000 mg a day, adverse events, liver enzymes, weight, glucose and lipids did not change, which is the safety record for the duration it covers.6 Wellgard's Beta NMN capsules supply 300 mg of NMN a day with 37.5 mg of trans-resveratrol and niacin and vitamin E at 20% of the reference intake; 300 mg equals the lowest arm of the 60-day trial and the level the European opinion assessed, and niacin contributes to normal energy-yielding metabolism.4, 7 What is NMN and is it safe in the UK carries the full trial table, the grey-hair and cancer questions and who should not take it; for an ingredient with a far longer trial record, see the Wellgard berberine guide.
Why do people stop taking NMN?
Four reasons dominate the forum threads. First, nothing noticed: at £30 or more a month, "no difference after three months" is the commonest, and it fits the trials, which found a longer walk and a higher blood number rather than anything that announces itself; the forum tally runs roughly two "fewer naps" to every "nothing".4, 8 Second, the cancer worry: a 2025 conference abstract in mice bred to develop cancer, not published in full, with no counterpart in the 15 human trials, where adverse events did not rise.6 Third, the niacin metabolite paper: in 2024 researchers linked high blood levels of 4PY, a breakdown product of surplus niacin, to cardiovascular events; NMN is a source of nicotinamide, so the question is fair, and no NMN trial has measured 4PY.9 Fourth, pregnancy or planning one, which is the right reason, since the safety assessment excludes it.7 Cost sits under all four. What nobody in the threads reports is stopping because something went wrong while taking it, which matches the trial record.
Why did a marketplace stop selling NMN?
Because in late 2022 the US regulator took the view that NMN, being under investigation there as a drug, could not also be sold as a supplement, and large US marketplaces removed listings. The regulator reversed that position in September 2025 and listings returned. None of it concerned safety, and none of it applied here: NMN is sold as a food supplement in the UK; it is not a medicine and is not banned.
Is there any harm in stopping suddenly?
No. There is nothing to taper. NMN does not suppress your own NAD production the way an external hormone suppresses a gland; your cells kept making NMN from food throughout. Missing a day, a fortnight away without it, or deciding on a Tuesday that you've had enough all amount to the same thing: blood NAD drifts back over the following weeks and you are where you started. If you want to restart, take the same dose with food. There is no loading phase and no reason to double up.
Frequently asked questions
Will my energy drop when I stop taking NMN?
No trial has measured it. If you noticed fewer afternoon dips while taking it, expect them to return gradually as blood NAD settles; if you noticed nothing, you will notice nothing.
Should I cycle NMN?
There is no evidence for or against it. Every trial dosed daily without breaks, for up to 24 weeks.6
Does stopping NMN undo anything?
Nothing was built, so nothing is undone. The six-minute-walk difference was measured during supplementation and has not been followed afterwards.4
Can I skip NMN for a few days?
Yes. Blood NAD took weeks to rise and will take weeks to fall; a forgotten weekend is irrelevant.2, 3
How long does NMN stay in your system?
The dose itself is processed within hours; the raised NAD pool it maintained settles back over weeks.1, 2
Sources
- Irie J, et al. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocrine Journal, 2020. PubMed 31685720.
- Okabe K, et al. Oral administration of nicotinamide mononucleotide is safe and efficiently increases blood NAD levels in healthy subjects. Frontiers in Nutrition, 2022. PubMed 35479740.
- Igarashi M, et al. Chronic nicotinamide mononucleotide supplementation in healthy older men. npj Aging, 2022. PubMed 35927255.
- Yi L, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomised placebo-controlled trial. GeroScience, 2023. PubMed 36482258.
- Kim M, et al. Nicotinamide mononucleotide for 12 weeks: sleep, fatigue and physical performance in older Japanese adults. Nutrients, 2022. PubMed 35215405.
- Yang W, et al. Safety and metabolism-related outcomes of oral nicotinamide mononucleotide supplementation in adults: meta-analysis. Nutrients, 2026. PubMed 42514320.
- EFSA NDA Panel. Safety of beta-nicotinamide mononucleotide (β-NMN) as a novel food and source of nicotinamide. EFSA Journal, 2026. PubMed 42125559.
- Zhang J, et al. Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: meta-analysis. Critical Reviews in Food Science and Nutrition, 2025. PubMed 39116016.
- Ferrell M, et al. A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk. Nature Medicine, 2024. PubMed 38374343.
This article is general information, not medical advice. If you are pregnant, breastfeeding, have had cancer or take prescribed medicines, ask your GP or pharmacist before starting or restarting NMN.